EW FY 2022 Earnings — Edwards Lifesciences Corporation Revenue & Financial Results | Market Cap Arena

EWEdwards Lifesciences Corporation

$50B

FY 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$5.4B+2.9% YoY

Gross Profit

$4.2B78.3% margin

Operating Income

$1.7B31.6% margin

Net Income

$1.5B28.3% margin

EPS (Diluted)

$2.44

Cash Flow

Operating Cash Flow

$1.2B

Free Cash Flow

$953M

Stock-Based Comp.

$127M

Balance Sheet

Total Assets

$8.3B

Total Liabilities

$2.5B

Stockholders' Equity

$5.8B

Cash & Equivalents

$769M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5.4B	$5.2B	+2.9%
Gross Profit	$4.2B	$4.0B	+5.2%
Operating Income	$1.7B	$1.6B	+5.7%
Net Income	$1.5B	$1.5B	+1.3%